Hasso Plattner Ventures

Hasso Plattner Ventures (HPV) is a distinguished European venture capital firm, founded in 2005 by Hasso Plattner, the co-founder of SAP. Based in Potsdam, Germany, the firm leverages its profound expertise in enterprise software and information technology to invest in rapidly expanding, tech-driven companies globally. HPV's core investment philosophy revolves around identifying and nurturing disruptive technologies and innovative business models, with a strong emphasis on the B2B software and enterprise tech sectors, including cutting-edge areas such as artificial intelligence, machine learning, and Software-as-a-Service (SaaS). The firm's unique advantage is rooted in its founder's extensive industry knowledge and vast network, providing portfolio companies with not only capital but also invaluable strategic guidance and market access.

HPV primarily focuses on early to growth-stage companies, typically participating in Series A, B, and C funding rounds. Their investment strategy is characterized by a long-term commitment, aiming to support companies through various critical growth phases. While initially concentrated on European startups, HPV has broadened its geographical scope to include promising ventures in the United States and Israel, reflecting a global perspective on technological innovation. The firm actively seeks out companies with robust management teams, a demonstrated product-market fit, and significant potential for scalability within large, addressable markets.

Beyond financial investment, Hasso Plattner Ventures provides substantial support to its portfolio companies through strategic advice, operational expertise, and access to a broad network of industry leaders and potential clients. This hands-on approach is designed to accelerate growth, facilitate market penetration, and optimize business operations. The firm has consistently demonstrated strong financial backing, having raised substantial funds throughout its history. For example, its second fund, launched in 2008, successfully secured €200 million, and its third fund, established in 2012, commanded €300 million, underscoring its capacity for significant investments. These substantial capital pools enable HPV to provide initial checks ranging from approximately $1.1 million to $11 million, with the flexibility to provide follow-on funding as companies scale and mature.